Biomarkers of histological response in lanifibranor-treated patients with metabolic dysfunction-associated steatohepatitis
Bron
Clinical gastroenterology and hepatology - ISSN 1542-3565-23:13 (2025) p. 1-18
Prevalence and risk factors of MASLD in prediabetes and Type 2 diabetes mellitus in Belgium and The Netherlands
Bron
Biomedicines - ISSN 2227-9059-13:11 (2025) p. 1-18
Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
Bron
Metabolism Open - ISSN 2589-9368-28 (2025) p. 1-12
Global performance of non-invasive tests in MASLD : insights from the G-MASLD study
Bron
Hepatology - ISSN 0270-9139- (2025) p.
Serial measurements of NIS2+® enable monitoring disease evolution in patients with MASH : a retrospective cohort analysis
Bron
Hepatology Communications - ISSN 2471-254X-9:12 (2025) p. 1-15